← to Company overview

Ampersand Capital Partners

Year founded
-
Country of origin
United States
HQ country
United States
Average deal value
Login to see more
Total deal value
Login to see more
Company industry
Private Equity
M&A expertise
-
Industry expertise
Private Equity
Company background

-

Latest deals
Ampersand Capital Partners acquires Julius Clinical 23-11-2023 € 25 - 50 million Ampersand Capital Partners acquires P95 02-05-2023 Undisclosed Biosynth Carbosynth acquires Pepscan 04-07-2022 € 100 - 250 million Ampersand acquires a stake in Tjoapack 28-04-2020 € 5 - 25 million Ampersand Capital Partners acquires GenDx from GenDx shareholders 06-05-2019 < € 5 million Show all deals
Deal team
Default Dealmaker photo
Hidde Alex Van Kerckhoven Vice President
Show all Dealmakers
Contact information

Want to see more?

Interested to see more details? Get your Dealmaker subscription today!

Start optimising your deal analysis Start optimising your deal analysis

Already have an account? Please login

Almost there!

You are only one step away from access to the most comprehensive deal database of the Netherlands and Belgium.

Start optimising your deal analysis Start optimising your deal analysis

Already have an account? Please login